Tables
Table 1 - Hepatitis B transmission risk by exposure type
04, Mar 2024
97.09 KB
Table 2 - Hepatitis C transmission risk by exposure type
04, Mar 2024
118.71 KB
Table 3 - HIV Transmission risk by exposure type
04, Mar 2024
77.83 KB
Table 4 - Hepatitis B post-exposure prophylaxis
04, Mar 2024
137.71 KB
Table 5 - Baseline and follow up testing
04, Mar 2024
57.9 KB
Table 6 - HIV PEP recommendations by type of exposure and source status
04, Mar 2024
176.99 KB
Table 7 - Impact of suppressive antiretroviral therapy on risk of HIV acquisition
04, Mar 2024
92.17 KB
Table 8 - Risk of HIV transmission per exposure where source is known to be living with HIV and not on ART
04, Mar 2024
68.26 KB
Table 9 - Estimated risk of HIV transmission by type of exposure where source HIV status is unknown
04, Mar 2024
123.04 KB
Table 9 - Estimated risk of HIV transmission by type of exposure where source HIV status is unknown
04, Mar 2024
123.04 KB
Table 10 - Suggested Paediatric PEP Regimens
04, Mar 2024
37.21 KB
Table 11 - HIV PEP drugs, doses and side effects
04, Mar 2024
145.8 KB
Ireland’s specialist service for the surveillance of communicable diseases.